Hilltelligence markHilltelligence
Archived This bill is from the 117th Congress (2021–2022) and is no longer under active consideration.
Bills/H.Res. 484117th Congress

Expressing the sense of the House of Representatives that the United States should not waive intellectual property rights relating to COVID-19 vaccines or treatments.

House: Referred
Cosponsors
20
Introduced
2021-06-17
Last action
2022-11-01

Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

Sign in to view Hilltelligence’s plain-English summary.

Action Timeline
  1. HouseLatest

    Referred to the Subcommittee on Courts, Intellectual Property, and the Internet.

  2. House

    Referred to the House Committee on the Judiciary.

  3. House

    Introduced in House

Sign in to view Hilltelligence’s passage-probability analysis.

Official Sources
Topics

Policy area

Commerce

Sign in to view Hilltelligence’s potential-cosponsor analysis.